Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Inwido | INWI | Nov 14, 2024 | 191.10 | 0.00 |
Irisity | IRIS | Nov 14, 2024 | 1.20 | +9.09 |
IRLAB Therapeutics A | IRLABA | Nov 14, 2024 | 14.00 | -1.06 |
Isofol Medical | ISOFOL | Nov 14, 2024 | 2.87 | 0.00 |
ITAB Shop Concept | ITAB | Nov 14, 2024 | 24.30 | 0.00 |
iZafe Group B | IZAFEB | Nov 14, 2024 | 0.21 | +11.96 |
Jetpak Top Holding | JETPAK | Nov 14, 2024 | 102.00 | -2.86 |
JLT Mobile Computers | JLT | Nov 14, 2024 | 2.98 | +1.36 |
JM | JM | Nov 14, 2024 | 184.00 | 0.00 |
Job Solution Sweden Holding AB (publ) | JOBS | Nov 14, 2024 | 23.40 | -1.68 |
John Mattson | JOMA | Nov 14, 2024 | 65.00 | -0.91 |
JonDeTech Sensors | JDT | Nov 14, 2024 | 2.38 | +5.31 |
JS Security | JSSEC | Nov 14, 2024 | 0.11 | -13.25 |
Jumpgate | GATE | Nov 14, 2024 | 4.39 | +1.15 |
K-Fast Holding B | KFASTB | Nov 14, 2024 | 20.55 | -0.48 |
K2A Knaust & Andersson Fastigheter B | K2AB | Nov 14, 2024 | 11.30 | -5.83 |
K2A Knaust & Andersson Fastigheter Pref | K2APREF | Nov 14, 2024 | 185.00 | -1.86 |
KABE Group B | KABEB | Nov 14, 2024 | 307.00 | -2.54 |
Kakel Max | KAKEL | Nov 14, 2024 | 10.50 | +6.06 |
Kallebäck Property Invest | KAPIAB | Nov 14, 2024 | 177.50 | 0.00 |
Kambi Group | KAMBI | Nov 14, 2024 | 106.00 | -0.84 |
Kancera | KAN | Nov 14, 2024 | 1.04 | +24.49 |
Karnell Group AB (publ) | KARNELB | Nov 14, 2024 | 46.94 | +0.95 |
Karnov Group | KAR | Nov 14, 2024 | 81.00 | +1.25 |
Karolinska Development B | KDEV | Nov 14, 2024 | 1.09 | +3.60 |
Katalysen Ventures AB | KAV | Nov 14, 2024 | 13.90 | +6.11 |
KebNi B | KEBNIB | Nov 14, 2024 | 0.95 | +2.92 |
Kentima Holding B | KENH | Nov 14, 2024 | 2.26 | +3.67 |
Kiliaro | KILI | Nov 14, 2024 | 0.20 | -4.65 |
Kinda Brave | BRAVE | Nov 14, 2024 | 1.66 | +12.16 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.